Silo Pharma (SILO) Current Deferred Revenue (2021 - 2026)
Silo Pharma (SILO) posted Current Deferred Revenue of $72102.0 for Q1 2026, little changed sequentially from $72102.0 in Q4 2025, and little changed YoY from $72102.0 in Q1 2025.
Silo Pharma (SILO) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Silo Pharma has reported Current Deferred Revenue for 6 years, with the latest figure at $72102.0 in Q1 2026.
- Quarterly Current Deferred Revenue changed 0.0% year-over-year to $72102.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $72102.0 (changed 0.0% YoY) and the FY2025 annual result came in at $72102.0, changed 0.0% from the prior year.
- Current Deferred Revenue held at $72102.0 in Q1 2026 per SILO's latest filing, from $72102.0 in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $1.0 million in Q2 2022 and troughed at $1676.0 in Q2 2024.
- A 5-year average of $113973.7 and a median of $72102.0 in 2022 frame the typical range for Current Deferred Revenue.
- The sharpest annual moves came in 2023 and 2025: Current Deferred Revenue tumbled 96.67% in 2023, then surged 4202.03% in 2025.
- Over 5 years, Current Deferred Revenue stood at $72102.0 in 2022, then changed by 0.0% to $72102.0 in 2023, then changed by 0.0% to $72102.0 in 2024, then changed by 0.0% to $72102.0 in 2025, then changed by 0.0% to $72102.0 in 2026.
- According to Business Quant data, Current Deferred Revenue over the past three periods registered $72102.0, $72102.0, and $72102.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 72,102.00 |
| Dec 31, 2025 | 72,102.00 |
| Sep 30, 2025 | 72,102.00 |
| Jun 30, 2025 | 72,102.00 |
| Mar 31, 2025 | 72,102.00 |
| Dec 31, 2024 | 72,102.00 |
| Sep 30, 2024 | 2,514.00 |
| Jun 30, 2024 | 1,676.00 |
| Mar 31, 2024 | 72,102.00 |
| Dec 31, 2023 | 72,102.00 |
| Sep 30, 2023 | 2,514.00 |
| Jun 30, 2023 | 34,375.00 |
| Mar 31, 2023 | 72,102.00 |
| Dec 31, 2022 | 72,102.00 |
| Sep 30, 2022 | 72,102.00 |
| Jun 30, 2022 | 1.03 Mn |
| Mar 31, 2022 | 72,102.00 |
| Dec 31, 2021 | 72,102.00 |
| Sep 30, 2021 | 1.03 Mn |
| Jun 30, 2021 | 1.03 Mn |